编者按:近期,由北京白求恩公益基金会发起,多位内分泌领域核心专家牵头撰写完成的《钠-葡萄糖共转运蛋白2抑制剂(SGLT2i)联合二甲双胍治疗2型糖尿病(T2DM)专家共识》(以下简称“共识”)发表于《国际内分泌代谢杂志》。这是中国首个专门针对SGLT2i联合二甲双胍治疗T2DM临床应用的指导性文件,为临床医生了解并规...
8(1):45.DOI:10.3390/jcm8010045. [2]Guillausseau PJ.Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes.A survey in general practice[J].Diabetes Metab
Although there is no universal conception of HFpEF, and the effects of SGLT2i are considered to be related to the studies’ design, SGLT2i are the only drugs that have shown efficacy in patients with HFpEF. Very recently, in the EMPEROR-Preserved Trial carried out in 5988 patients with HF...
钠-葡萄糖共转运蛋白2抑制剂(SGLT2i)在治疗2型糖尿病中的有效性和安全性重点
[1]Milder TY,Stocker SL,Abdel Shaheed C,et al.Combination therapy with an SGLT2 inhibitor as initial treatment for type 2 diabetes:a systematic review and meta-analysis[J].J Clin Med.2019,8(1):45.DOI:10.3390/jcm8010045. [2]Guillausseau PJ.Influence of oral antidiabetic drugs compliance ...